213 related articles for article (PubMed ID: 28922388)
1. Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers.
Bai Y; Qiao L; Xie N; Shi Y; Liu N; Wang J
PLoS One; 2017; 12(9):e0184902. PubMed ID: 28922388
[TBL] [Abstract][Full Text] [Related]
2. The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers.
Li Y; Huang J; Sun J; Xiang S; Yang D; Ying X; Lu M; Li H; Ren G
Oncotarget; 2017 Jan; 8(3):4501-4519. PubMed ID: 27966459
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Expression of
Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H
Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702
[TBL] [Abstract][Full Text] [Related]
4. BTG/Tob family members Tob1 and Tob2 inhibit proliferation of mouse embryonic stem cells via Id3 mRNA degradation.
Chen Y; Wang C; Wu J; Li L
Biochem Biophys Res Commun; 2015 Jul; 462(3):208-14. PubMed ID: 25951976
[TBL] [Abstract][Full Text] [Related]
5. A pan-cancer analysis of anti-proliferative protein family genes for therapeutic targets in cancer.
Zhang S; Gu J; Shi LL; Qian B; Diao X; Jiang X; Wu J; Wu Z; Shen A
Sci Rep; 2023 Dec; 13(1):21607. PubMed ID: 38062199
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system.
Sasajima H; Nakagawa K; Yokosawa H
Eur J Biochem; 2002 Jul; 269(14):3596-604. PubMed ID: 12135500
[TBL] [Abstract][Full Text] [Related]
7. A conserved motif in human BTG1 and BTG2 proteins mediates interaction with the poly(A) binding protein PABPC1 to stimulate mRNA deadenylation.
Amine H; Ripin N; Sharma S; Stoecklin G; Allain FH; Séraphin B; Mauxion F
RNA Biol; 2021 Dec; 18(12):2450-2465. PubMed ID: 34060423
[TBL] [Abstract][Full Text] [Related]
8. Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients.
Wu CC; Ekanem TI; Phan NN; Loan DTT; Hou SY; Lee KH; Wang CY
Int J Med Sci; 2020; 17(18):3112-3124. PubMed ID: 33173433
[TBL] [Abstract][Full Text] [Related]
9. The mammalian anti-proliferative BTG/Tob protein family.
Winkler GS
J Cell Physiol; 2010 Jan; 222(1):66-72. PubMed ID: 19746446
[TBL] [Abstract][Full Text] [Related]
10. The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex.
Doidge R; Mittal S; Aslam A; Winkler GS
PLoS One; 2012; 7(12):e51331. PubMed ID: 23236473
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of the centromere protein-A(CENP-A)-encoding gene as a prognostic and predictive biomarker in human cancers.
Sun X; Clermont PL; Jiao W; Helgason CD; Gout PW; Wang Y; Qu S
Int J Cancer; 2016 Aug; 139(4):899-907. PubMed ID: 27062469
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of TOB/BTG family members in patients with plaque psoriasis: cross-sectional study.
Barrera-Ochoa CA; Fonseca-Camarillo G; Vega-Memije ME; Furuzawa-Carballeda J; Uriarte-Ruiz K; Fernández-Camargo DA; Yamamoto-Furusho JK
Immunol Res; 2024 Apr; 72(2):234-241. PubMed ID: 37874431
[TBL] [Abstract][Full Text] [Related]
13. BTG2: a rising star of tumor suppressors (review).
Mao B; Zhang Z; Wang G
Int J Oncol; 2015 Feb; 46(2):459-64. PubMed ID: 25405282
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer.
Huang C; Liu J; Xiong B; Yonemura Y; Yang X
Gene; 2019 Feb; 685():202-210. PubMed ID: 30415009
[TBL] [Abstract][Full Text] [Related]
15. Expression of TOB/BTG family members in patients with inflammatory bowel disease.
Fonseca-Camarillo G; Furuzawa-Carballeda J; Priego-Ranero ÁA; Martínez-Benítez B; Barreto-Zúñiga R; Yamamoto-Furusho JK
Scand J Immunol; 2021 Apr; 93(4):e13004. PubMed ID: 33247598
[TBL] [Abstract][Full Text] [Related]
16. The clinicopathological and prognostic significances of Dkk3 expression in cancers: A bioinformatics analysis.
Chen GY; Zheng HC
Cancer Biomark; 2018; 23(3):323-331. PubMed ID: 29843219
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers.
Kumar D; Hassan MK; Pattnaik N; Mohapatra N; Dixit M
PLoS One; 2017; 12(10):e0186977. PubMed ID: 29073199
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognosis analyses of the fibronectin type-III domain-containing (FNDC) protein family in human cancers: A Review.
Jiang H; Chu BL; He J; Liu Z; Yang L
Medicine (Baltimore); 2022 Dec; 101(49):e31854. PubMed ID: 36626432
[TBL] [Abstract][Full Text] [Related]
19. In search of a function for the TIS21/PC3/BTG1/TOB family.
Matsuda S; Rouault J; Magaud J; Berthet C
FEBS Lett; 2001 May; 497(2-3):67-72. PubMed ID: 11377414
[TBL] [Abstract][Full Text] [Related]
20. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
